Mustang Bio Statistics
Total Valuation
Mustang Bio has a market cap or net worth of $6.57 million. The enterprise value is -$12.42 million.
Important Dates
The next estimated earnings date is Friday, March 27, 2026, before market open.
| Earnings Date | Mar 27, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Mustang Bio has 7.30 million shares outstanding. The number of shares has increased by 800.12% in one year.
| Current Share Class | 6.45M |
| Shares Outstanding | 7.30M |
| Shares Change (YoY) | +800.12% |
| Shares Change (QoQ) | +55.22% |
| Owned by Insiders (%) | 0.05% |
| Owned by Institutions (%) | 17.42% |
| Float | 5.07M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.67 |
| P/TBV Ratio | 0.67 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.05
| Current Ratio | 2.05 |
| Quick Ratio | 2.03 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -347.20 |
Financial Efficiency
Return on equity (ROE) is -418.83% and return on invested capital (ROIC) is -103.43%.
| Return on Equity (ROE) | -418.83% |
| Return on Assets (ROA) | -8.17% |
| Return on Invested Capital (ROIC) | -103.43% |
| Return on Capital Employed (ROCE) | -17.50% |
| Weighted Average Cost of Capital (WACC) | 16.13% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$389,167 |
| Employee Count | 6 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -69.28% in the last 52 weeks. The beta is 2.16, so Mustang Bio's price volatility has been higher than the market average.
| Beta (5Y) | 2.16 |
| 52-Week Price Change | -69.28% |
| 50-Day Moving Average | 1.05 |
| 200-Day Moving Average | 1.39 |
| Relative Strength Index (RSI) | 45.10 |
| Average Volume (20 Days) | 432,609 |
Short Selling Information
The latest short interest is 40,129, so 0.55% of the outstanding shares have been sold short.
| Short Interest | 40,129 |
| Short Previous Month | 51,498 |
| Short % of Shares Out | 0.55% |
| Short % of Float | 0.79% |
| Short Ratio (days to cover) | 0.48 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -1.74M |
| Pretax Income | -2.34M |
| Net Income | -2.34M |
| EBITDA | -1.65M |
| EBIT | -1.74M |
| Earnings Per Share (EPS) | -$0.66 |
Full Income StatementBalance Sheet
The company has $18.98 million in cash and n/a in debt, with a net cash position of $18.98 million or $2.60 per share.
| Cash & Cash Equivalents | 18.98M |
| Total Debt | n/a |
| Net Cash | 18.98M |
| Net Cash Per Share | $2.60 |
| Equity (Book Value) | 9.77M |
| Book Value Per Share | 1.34 |
| Working Capital | 9.92M |
Full Balance SheetCash Flow
| Operating Cash Flow | -5.54M |
| Capital Expenditures | n/a |
| Free Cash Flow | -5.54M |
| FCF Per Share | -$0.76 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
